Last reviewed · How we verify
Enoxaparin Sodium Injection; Rivaroxaban Tablets
Enoxaparin Sodium Injection; Rivaroxaban Tablets is a Anticoagulant Small molecule drug developed by Beijing Suncadia Pharmaceuticals Co., Ltd. It is currently in Phase 2 development for Prophylaxis and treatment of deep vein thrombosis, pulmonary embolism, and stroke prevention in atrial fibrillation.
Enoxaparin sodium injection works by inhibiting Factor Xa and Factor IIa, preventing blood clot formation, while rivaroxaban tablets inhibit Factor Xa directly.
Enoxaparin sodium injection works by inhibiting Factor Xa and Factor IIa, preventing blood clot formation, while rivaroxaban tablets inhibit Factor Xa directly. Used for Prophylaxis and treatment of deep vein thrombosis, pulmonary embolism, and stroke prevention in atrial fibrillation.
At a glance
| Generic name | Enoxaparin Sodium Injection; Rivaroxaban Tablets |
|---|---|
| Sponsor | Beijing Suncadia Pharmaceuticals Co., Ltd |
| Drug class | Anticoagulant |
| Target | Factor Xa, Factor IIa |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 2 |
Mechanism of action
Enoxaparin sodium injection is a low molecular weight heparin that exerts its anticoagulant effect by binding to antithrombin III, thereby inhibiting Factor Xa and Factor IIa. Rivaroxaban tablets, on the other hand, directly inhibits Factor Xa, a key enzyme in the coagulation cascade. This dual mechanism of action helps prevent the formation of blood clots and reduce the risk of stroke and other thromboembolic events.
Approved indications
- Prophylaxis and treatment of deep vein thrombosis, pulmonary embolism, and stroke prevention in atrial fibrillation
Common side effects
- Major bleeding
- Hemorrhage
- Thrombocytopenia
Key clinical trials
- A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants (PHASE1)
- Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies (NA)
- A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery (PHASE2)
- Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Enoxaparin Sodium Injection; Rivaroxaban Tablets CI brief — competitive landscape report
- Enoxaparin Sodium Injection; Rivaroxaban Tablets updates RSS · CI watch RSS
- Beijing Suncadia Pharmaceuticals Co., Ltd portfolio CI
Frequently asked questions about Enoxaparin Sodium Injection; Rivaroxaban Tablets
What is Enoxaparin Sodium Injection; Rivaroxaban Tablets?
How does Enoxaparin Sodium Injection; Rivaroxaban Tablets work?
What is Enoxaparin Sodium Injection; Rivaroxaban Tablets used for?
Who makes Enoxaparin Sodium Injection; Rivaroxaban Tablets?
What drug class is Enoxaparin Sodium Injection; Rivaroxaban Tablets in?
What development phase is Enoxaparin Sodium Injection; Rivaroxaban Tablets in?
What are the side effects of Enoxaparin Sodium Injection; Rivaroxaban Tablets?
What does Enoxaparin Sodium Injection; Rivaroxaban Tablets target?
Related
- Drug class: All Anticoagulant drugs
- Target: All drugs targeting Factor Xa, Factor IIa
- Manufacturer: Beijing Suncadia Pharmaceuticals Co., Ltd — full pipeline
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Prophylaxis and treatment of deep vein thrombosis, pulmonary embolism, and stroke prevention in atrial fibrillation
- Compare: Enoxaparin Sodium Injection; Rivaroxaban Tablets vs similar drugs
- Pricing: Enoxaparin Sodium Injection; Rivaroxaban Tablets cost, discount & access